Global Galectin Inhibitor Therapeutics Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 150.00 Billion |
 Market Size (Forecast Year) |
USD 271.53 Billion |
 CAGR |
% |
| Major Markets Players |
>全球半乳糖凝集素抑制剂治疗市场，按适应症（纤维化、癌症免疫治疗、皮肤病学、其他）、给药途径（口服、肠胃外、其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房）划分 - 行业趋势和预测到 2029 年。
市场分析和见解
半乳糖凝集素抑制剂治疗学是指一组机器人系统、组件、配件和解决方案，它们具有先进的技术，可提供高精度和帮助外科医生进行多种腹部外科手术，例如胃、胆囊、肠、肝、胰腺、脾脏和阑尾。
半乳糖凝集素抑制剂疗法具有支持作用，旨在减轻症状的严重程度。Data Bridge Market Research 分析，2021 年半乳糖凝集素抑制剂疗法市场价值为 1.5 亿美元，到 2029 年可能达到 2.7153 亿美元，在 2022 年至 2029 年的预测期内将以 7.7% 的复合年增长率增长。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
适应症（纤维化、癌症免疫治疗、皮肤病学、其他）、给药途径（口服、肠胃外、其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房） |
|
覆盖国家 |
美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区 |
|
涵盖的市场参与者 |
Galectin Therapeutics Inc（美国）、MandalMed, Inc（美国）、G3 Pharmaceuticals（印度）、Angion（美国）、iTeos（美国）、GlycoMimetics（美国）、Galecto Biotech（丹麦）、Novartis AG（瑞士）、Pfizer Inc.（美国）、Lilly（美国）。 |
|
市场机会 |
|
半乳糖凝集素抑制剂治疗 市场动态
驱动程序
预计在预测期内推动半乳糖凝集素抑制剂治疗市场增长的主要因素如下：
- 许多制药公司不断进行临床试验
多项临床研究结果表明，半乳糖凝集素疗法可能是一种可行的癌症治疗选择，这是推动市场增长的主要因素之一。
- 多种癌症发病率上升
Growing cases of patients suffering from various form of cancer such as advanced melanoma and other malignancies.
- The growing knowledge of cancer, especially in advancing countries
As there is a rise in the number of cases of cancer, people have started becoming more aware of the ailment and its treatment options medically and surgically which is further estimated to cushion the growth of the market.
Opportunities
In addition, the rising need for efficient treatment of cancer and fibrosis with decreased adverse effects and technological developments will further provide potential opportunities for the growth of the galectin inhibitor therapeutics market in the coming years.
Restraints/Challenges
On the flip side, the strict regulations imposed by regulatory authorities is further projected to impede the growth of the galectin inhibitor therapeutics market in the timeline period. However, the catastrophe of several clinical trials might further challenge the growth of the galectin inhibitor therapeutics market in the near future.
This galectin inhibitor therapeutics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on galectin inhibitor therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
The galectin inhibitor therapeutics market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Covid-19 Impact on Galectin Inhibitor Therapeutics Market
The pandemic of COVID-19 has had a huge impact on the galectin inhibitor therapeutics market. biotech and pharmaceutical companies are appointed in collaboration work to deal with Covid-19. This has led to the shifting of their focus and also all the resources from making other drugs to coronavirus vaccines. Manufacturing industries are being shuttered around the world due to lockdown causing an unprecedented technology and business model transformation. However, in the post-COVID scenario, galectin inhibitor therapeutics market is projected to be significantly impacted due to the focus of all research institutes, biotech, and pharmaceutical businesses has turned back to supporting healthcare systems and other facilities. There has been an increase in the number of abdominal procedures recently.
Global Galectin Inhibitor Therapeutics Market Scope
The galectin inhibitor therapeutics market is segmented on the basis of indication, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
- Fibrosis
- Cancer Immunotherapy
- Dermatology
- Others
On the basis of indication, the galectin inhibitor therapeutics market is segmented into fibrosis, cancer immunotherapy, dermatology and others.
Route of Administration
- Oral
- Parenteral
- Others
On the basis of route of administration, the galectin inhibitor therapeutics market is segmented into oral, parenteral and others.
End Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
On the basis of end users, the galectin inhibitor therapeutics market is segmented into hospitals, homecare, specialty clinics and others.
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
On the basis of distribution channel, the galectin inhibitor therapeutics market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.
Galectin Inhibitor Therapeutics Market Regional Analysis/Insights
The galectin inhibitor therapeutics market is analysed and market size insights and trends are provided by country, ty indication, route of administration, end users and distribution channel as referenced above.
The countries covered in the galectin inhibitor therapeutics market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
由于半乳糖凝集素类疗法研发活动的增加，北美在半乳糖凝集素抑制剂治疗市场占据主导地位。此外，预测期内，患纤维化疾病的患者人数不断增加，将进一步推动该地区半乳糖凝集素抑制剂治疗市场的增长。
由于临床设施的完善，预计欧洲半乳糖凝集素抑制剂治疗市场将在 2022 年至 2029 年的预测期内出现大幅增长。此外，纤维化疾病患者寻求更好治疗的比例不断提高，预计未来几年将进一步推动该地区半乳糖凝集素抑制剂治疗市场的增长。
报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。
竞争格局和半乳糖凝集素抑制剂治疗 市场份额分析
半乳糖凝集素抑制剂治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对半乳糖凝集素抑制剂治疗市场的关注有关。
半乳糖凝集素抑制剂治疗市场的一些主要参与者包括：
- Galectin Therapeutics Inc（美国）
- MandalMed, Inc（美国）
- G3 Pharmaceuticals（印度）
- Angion（美国）
- iTeos（美国）
- 糖模拟物 (美国)
- Galecto Biotech（丹麦）
- 诺华公司（瑞士）
- 辉瑞公司（美国），
- 礼来（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
